← Back to Clinical Trials
Recruiting NCT05975697

NCT05975697 The EFFECT of FUNCTIONAL ELECTRICAL STIMULATING on PHYSICAL ACTIVITY and QUALITY of LIFE in PATIENTS with PARALIS AFTER THROMBECTOMY: a RANDOMIZED CONTROLLED STUDY

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05975697
Status Recruiting
Phase
Sponsor Cukurova University
Condition Thrombectomy
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-07-20
Primary Completion 2025-03-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Experimental group to be applied FES

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-07-20 with a primary completion date of 2025-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

It is planned as a randomized controlled intervention study to determine the effect of functional electrical stimulation (FES) on physical activity and quality of life in patients with paralysis after thrombectomy.

Eligibility Criteria

Inclusion Criteria: * Over 18 years old, * Thrombectomy procedure was performed, * Glasgow Coma Score (GCS) \> 12 after thrombectomy * Able to communicate, * Having upper extremity paralysis, * No pacemaker, advanced spasticity and muscle atrophy, peripheral lesions, osteoporosis, skin irritation and obesity, * No skin and peripheral circulation problems, * Patients whose relatives gave consent to the research. Exclusion Criteria: * Patients who did not comply with the sampling criteria and who developed complications that caused brain damage during the study (convulsions, mental disorder/delirium, vomiting, tremor, myoclonus) and whose relatives did not approve of the study will not be included in the study.

Contact & Investigator

Central Contact

Ceylan Kişial, Master

✉ cylnksl@gmail.com

📞 05068010561

Frequently Asked Questions

Who can join the NCT05975697 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Thrombectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05975697 currently recruiting?

Yes, NCT05975697 is actively recruiting participants. Contact the research team at cylnksl@gmail.com for enrollment information.

Where is the NCT05975697 trial being conducted?

This trial is being conducted at Adana, Turkey (Türkiye).

Who is sponsoring the NCT05975697 clinical trial?

NCT05975697 is sponsored by Cukurova University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology